The US FDA wants more enforcement authority over quality corrections that may not necessarily prevent approval, but still are necessary.
Agency officials want the ability to require specific changes or quality updates from sponsors after product approval to ensure the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?